Abbott Laboratories
Close on Nov 2, 2026Market cap $190.62BP/E 35.4Yield 2.18%
Abbott Laboratories Diabetes Care Division International by Year
Diabetes Care Division (FreeStyle Libre CGM & Blood Glucose Monitoring) International — Reported Sales Growth (%) (%)
Abbott Laboratories Diabetes Care Division International: 15.4% in FY2025, up 0.5 pts from a year earlier.
Where the FY2025 figure comes from
“|| Sales 12M25 ($ in millions) | Total | Rhythm Management | Electro- physiology | Heart Failure | Vascular | Structural Heart | Neuro-modulation | Diabetes Care || International | 12.0 | 6.4 | 11.7 | 16.4 | 5.4 | 13.0 | 21.5 | 15.4”
Source: SEC Filing (0001628280-26-002982) ↗
Reported in Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diabetes Care Division (FreeStyle Libre CGM & Blood Glucose Monitoring) International — Reported Sales Growth (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.4% | +0.5 pts | SEC Filing (0001628280-26-002982) ↗ |
| FY2024 | Dec 31, 2024 | 14.9% | -1.4 pts | SEC Filing (0001628280-25-002092) ↗ |
| FY2023 | Dec 31, 2023 | 16.3% | +16.1 pts | SEC Filing (0001628280-24-002009) ↗ |
| FY2022 | Dec 31, 2022 | 0.2% | -29.4 pts | SEC Filing (0001628280-23-001516) ↗ |
| FY2021 | Dec 31, 2021 | 29.6% | -0.6 pts | SEC Filing (0001104659-22-007648) ↗ |
| FY2020 | Dec 31, 2020 | 30.2% | +5.1 pts | SEC Filing (0001104659-21-007942) ↗ |
| FY2019 | Dec 31, 2019 | 25.1% | -11.3 pts | SEC Filing (0001104659-20-005717) ↗ |
| FY2018 | Dec 31, 2018 | 36.4% | +4.0 pts | SEC Filing (0001104659-19-002848) ↗ |
| FY2017 | Dec 31, 2017 | 32.4% | +19.4 pts | SEC Filing (0001104659-18-003691) ↗ |
| FY2016 | Dec 31, 2016 | 13.0% | +7.2 pts | SEC Filing (0001104659-17-003920) ↗ |
| FY2015 | Dec 31, 2015 | 5.8% | – | SEC Filing (0001104659-16-091861) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Diabetes Care Division International (%), annual FY2015–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/md-dc-yoy-rep-intl
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.